Median Log₁₀ HIV-1 RNA Level During the First Month of Antiretroviral Therapy among 13 Kenyan Men.

<p>P values given are for paired comparisons to baseline levels for each sample type.</p><p>IQR  =  Inter-quartile range.</p>*<p>Due to public holidays or other scheduling difficulties, eleven visits (15.9%) occurred one day before or one day after the scheduled visit date.</p>†<p>One day 7 visit was missed and two day 28 visits were missed. All semen samples were missing for one participant. Blood samples were missing on day 7 (2 samples) and day 14 (1 sample).</p

Decrease in HIV-1 RNA in blood and semen during the first month of antiretroviral therapy.

<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0043086#pone-0043086-g001" target="_blank">Figure 1a</a> presents results for blood plasma, and <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0043086#pone-0043086-g001" target="_blank">Figure 1b</a> presents results for seminal plasma. Open, connected circles represent included data points (see methods). The bold line represents the modeled estimate. Delta (δ) is the estimate for the initial, rapid phase of decay, and mu (μ) the estimate for the subsequent, slower phase of decay. The half-life in days for each phase is equal to ln(2) divided by the decay rate in log₁₀ virions/day. P values are presented for comparisons of the two decay rates in seminal plasma to those seen in blood plasma. NA = not applicable.</p